John Dooley, MD
Pain Medicine · Davenport, IANPI 1326005703
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,977 of the $6,481 with a category attached, or 61.4%. 21 manufacturers reported payments, led by Medtronic at 47.2% of the total. Reporting peaked in 2023 at $2,335 and has fallen 81.1% since, to $442 in 2025.
Across 141 payments — averaging $45.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Boston Scientific$2K
- Vertos Medical, Inc.$219
- Abbott$215
- SPR Therapeutics, Inc$181
- Lilly USA, LLC$130
- plus $485 from 15 others
What the payments were for
- Travel & lodging$2,50339%
- Food & beverage$3,97761%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 44 | $3,058 |
| Boston Scientific | 44 | $2,193 |
| Vertos Medical, Inc. | 3 | $219 |
| Abbott | 13 | $215 |
| SPR Therapeutics, Inc | 6 | $181 |
| Lilly USA, LLC | 8 | $130 |
| Stimwave Technologies Incorporated | 1 | $88 |
| Biodelivery Sciences International, Inc. | 4 | $59 |
| Johnson & Johnson | 2 | $53 |
| Nevro Corp. | 3 | $51 |
| Bioventus LLC | 2 | $42 |
| Pacira Therapeutics, Inc. | 2 | $32 |
| Biotronik NRO, Inc. | 1 | $26 |
| Merck | 1 | $25 |
| Alkermes, Inc. | 1 | $19 |
| Teleflex LLC | 1 | $19 |
| Piramal Critical Care | 1 | $19 |
| Radius Health, Inc. | 1 | $15 |
| Flowonix Medical Incorporated | 1 | $13 |
| Foundation Fusion Solutions, LLC | 1 | $13 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,481 in reported general payments places this provider in the 80th percentile of 31 pain medicine providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 40 | $860 |
| Nabumetone | 53 | $481 |
| Morphine Sulfate ErMorphine Sulfate | 16 | $292 |
| Tramadol Hcl | 14 | $178 |
| Meloxicam | 15 | $43 |
| Prednisone | 11 | $20 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Davenport
- Timothy MillerDavenport$4K
- Celeste MillerDavenport$2K
- Timothy MavesDavenport$190
- Garry ClarkSioux City$189K
- Jolene SmithClive$85K
- Daniel MoyseDes Moines$40K
- Christopher StalveyWest Des Moines$14K
- William ChangIowa City$9K
- Joysree SubramanianIowa City$9K
- John RayburnDes Moines$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.